Guangzhou Yuao Trading
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Guangzhou Yuao Trading between 25 Nov 2025 and 6 May 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
Guangzhou Yuao Trading
Retatrutide
Tested 4 Samples
Last test 6 May 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Guangzhou Yuao Trading
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
6 May 2026
First
25 Nov 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 6 May 2026 | View | 15mg | 15.2mg | +1.3% | 99.90% | (no batch ID) | White Label / Silver Crimp / Clear Cap | Lab E | Public | |
| 18 Mar 2026 | View | 10mg | 8.45mg | -15.5% | 99.90% | (no batch ID) | (no data) | Lab E | Public | |
| 7 Mar 2026 | View | 10mg | 10.8mg | +8.0% | 99.80% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab G | Public | |
| 25 Nov 2025 | View | 20mg | 20mg | 99.95% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | ||